PORCELLI, BRUNETTA
 Distribuzione geografica
Continente #
EU - Europa 13.985
NA - Nord America 12.957
AS - Asia 3.143
SA - Sud America 225
AF - Africa 67
Continente sconosciuto - Info sul continente non disponibili 26
OC - Oceania 22
Totale 30.425
Nazione #
US - Stati Uniti d'America 12.891
GB - Regno Unito 3.513
IE - Irlanda 2.403
IT - Italia 2.116
CN - Cina 1.955
UA - Ucraina 1.487
SE - Svezia 1.208
RU - Federazione Russa 982
SG - Singapore 967
FR - Francia 796
DE - Germania 768
FI - Finlandia 408
BR - Brasile 189
ES - Italia 72
NL - Olanda 59
CA - Canada 45
CI - Costa d'Avorio 35
TR - Turchia 33
IN - India 28
BE - Belgio 27
EU - Europa 24
VN - Vietnam 23
AU - Australia 21
RO - Romania 16
HK - Hong Kong 15
AT - Austria 14
JP - Giappone 14
GR - Grecia 12
HU - Ungheria 12
CZ - Repubblica Ceca 11
PL - Polonia 11
AR - Argentina 10
AZ - Azerbaigian 9
EG - Egitto 9
CH - Svizzera 8
MX - Messico 8
PK - Pakistan 8
IR - Iran 7
JO - Giordania 7
LK - Sri Lanka 7
MA - Marocco 7
PH - Filippine 7
CL - Cile 6
DZ - Algeria 6
LV - Lettonia 6
BG - Bulgaria 5
BO - Bolivia 5
CO - Colombia 5
EC - Ecuador 5
EE - Estonia 5
GE - Georgia 5
IL - Israele 5
MD - Moldavia 5
MY - Malesia 5
MZ - Mozambico 5
RS - Serbia 5
AE - Emirati Arabi Uniti 4
AL - Albania 4
BD - Bangladesh 4
DK - Danimarca 4
IQ - Iraq 4
KZ - Kazakistan 4
LT - Lituania 4
NO - Norvegia 4
PA - Panama 4
PT - Portogallo 4
SA - Arabia Saudita 4
UZ - Uzbekistan 4
AM - Armenia 3
CR - Costa Rica 3
HN - Honduras 3
HR - Croazia 3
LU - Lussemburgo 3
SK - Slovacchia (Repubblica Slovacca) 3
ZA - Sudafrica 3
BY - Bielorussia 2
CY - Cipro 2
ID - Indonesia 2
JM - Giamaica 2
KG - Kirghizistan 2
KH - Cambogia 2
KW - Kuwait 2
MT - Malta 2
NP - Nepal 2
PE - Perù 2
VE - Venezuela 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AF - Afghanistan, Repubblica islamica di 1
BH - Bahrain 1
DO - Repubblica Dominicana 1
IM - Isola di Man 1
KE - Kenya 1
KR - Corea 1
LA - Repubblica Popolare Democratica del Laos 1
LY - Libia 1
MK - Macedonia 1
NZ - Nuova Zelanda 1
OM - Oman 1
QA - Qatar 1
SM - San Marino 1
Totale 30.420
Città #
Southend 3.337
Dublin 2.390
Fairfield 1.393
Chandler 1.285
Jacksonville 1.225
Santa Clara 891
Ashburn 826
Wilmington 624
Woodbridge 612
Princeton 504
Beijing 495
Houston 469
Nanjing 449
Seattle 444
Siena 434
Cambridge 433
Menlo Park 395
Ann Arbor 378
Singapore 347
New York 237
Boardman 189
Helsinki 160
Nanchang 153
Milan 144
San Mateo 138
San Diego 122
Dearborn 118
Moscow 107
Shenyang 107
Rome 106
Florence 84
Shanghai 80
Hebei 71
Kunming 71
Tianjin 66
Málaga 64
Council Bluffs 56
Changsha 54
Jiaxing 54
Jinan 49
Los Angeles 46
Düsseldorf 45
Norwalk 44
Redwood City 43
San Francisco 38
Abidjan 35
Ningbo 35
Hangzhou 33
Zhengzhou 29
Naples 28
Toronto 28
London 27
Guangzhou 26
Brussels 25
Pescara 24
Bologna 23
Munich 23
Hefei 20
Venezia 20
Lancaster 19
Nuremberg 19
São Paulo 19
Dong Ket 18
Izmir 18
Washington 18
Padova 17
Brasília 14
Fremont 14
Dallas 13
Turin 13
Falls Church 12
Palermo 12
Taizhou 12
Athens 11
Lanzhou 11
Melbourne 11
Parma 11
Salerno 11
Verona 11
Catania 10
Fuzhou 10
Baku 9
Bari 9
Changchun 9
Saint Petersburg 9
Stockholm 9
Amsterdam 8
Budapest 8
Cascina 8
Chieti 8
Genova 8
Groningen 8
Lucca 8
Torino 8
Colombo 7
Livorno 7
Montebelluna 7
Ottawa 7
Piscataway 7
Prato 7
Totale 20.208
Nome #
Potenziale endogeno di trombina (ETP) e parametri di screening della coagulazione. Comparazione tra INR, D-Dimero ed ETP in una popolazione di soggetti anticoagulati con Warfarin per fibrillazione atriale cronica. 306
Association between stressful life events and autoimmune diseases: A systematic review and meta-analysis of retrospective case-control studies 281
Endogenous thrombin potential and screening parameters of coagulation [Potenziale endogeno di trombina e parametri di screening della coagulazione] 274
Aggiornamento delle linee guida SIPMeL sull’utilizzo dei test autoanticorpali nella diagnosi e nel monitoraggio delle malattie autoimmuni reumatiche sistemiche: metodi per lo screening degli anticorpi anti-antigeni cellulari (ANA). Updating the Italian Society of Clinical Pathology and Laboratory Medicine guidelines on the use of autoantibody tests in the diagnosis and monitoring of systemic rheumatic autoimmune diseases: analytical methods for the screening of antibodies to cellular antigens (ANA). 273
Assessment of new method to typing HLA in celiac disease [Valutazione di un nuovo metodo per la tipizzazione HLA nella malattia celiaca] 265
Analisi dell’acido urico e delle ossipurine nei soggetti normali e nei soggetti gottosi 232
A study on the association of mood disorders and gluten-related diseases 198
Determinazione dei peptidi immunogenici di glutine nelle urine e nelle feci di pazienti celiaci a dieta gluten-free. 189
Association between stressful life events and autoimmune diseases: a systematic review and meta-analysis of retrospective case-control studies 186
Prevalence of hypophysitis in a cohort of patients with metastatic melanoma and prostate cancer treated with ipilimumab 181
Determination of p185 and adenylosuccinate lyase (ASL) activity in preneoplastic colon lesions and intestinal mucosa of human subjects 179
Immunohistochemical analysis of P185 and asl activity in pre-neoplastic lesions and intestinal mucosa of human subjects 174
Assessment of a test for the screening and diagnosis of celiac disease 171
Large-scale screening of organ specific autoantibodies in patients with autoimmune thyroid diseases 171
Statistical analysis of effects of testosterone on purine metabolism in rat liver. 170
Disturbi dell’umore e malattia celiaca: esiste un’associazione? 169
Celiac and non-celiac gluten sensitivity: a review on the association with schizophrenia and mood disorders 168
Determinazione degli anticoagulanti orali diretti in regime di urgenza. [Determination of direct oral anticoagulants in urgency] 164
Comparison of high- and low-energy collision spectra in the characterization of endogenous and exogenous purine bases 161
Study of purine catabolism using 14C-glycine as tracer 161
Synthetic gel of carotid artery plaque 161
Antibody pattern of celiac disease and gluten sensitivity in anxiety disorders 160
EPR Spin Trapping of a radical intermediate in the urate oxidase reaction 156
Non celiac gluten sensitivity and psychiatric disorders: a pilot study to compare anxiety disorders and mood disorders 154
Plasma Oxypurines in Gastric and Colorectal Cancer 153
Determinazione dell'acido folico in soggetti sottoposti a gastrectomia 153
Antioxidant status in peripheral vascular atherosclerosis 151
Potenziale endogeno di trombina e parametri di screening della coagulazione. 151
Antibody pattern of celiac disease and gluten sensitivity in mood disorders 151
Ruolo degli autoanticorpi nella diagnosi della colangite sclerosante primitiva 149
Total aripiprazole dosage: Setting up the method on the cobas® 8000 analyzer [Dosaggio dell’aripiprazolo totale: messa a punto del metodo su analizzatore Cobas 8000] 149
Autoantibody profiling of patients with primary biliary cirrhosis using a multiplexed line-blot assay 148
Disturbi dell’umore e patologie glutine correlate. Mood disorders and gluten-related diseases 148
Fecal gluten immunogenic peptides as indicators of dietary compliance in celiac patients. 148
Dosaggio del Rivaroxaban in urgenza 146
A new diagnostic algorithm for pattern-oriented autoantibody testing according to the ICAP nomenclature: A pilot study 145
Prelievi anche nel pomeriggio e stop al digiuno: innovazioni per una medicina di laboratorio 4.0 144
Some aspects of purine nucleotide metabolism in lymphocytes of B-CLL 143
Different mass spectrometric approaches in the identification of endogenous methylated purine bases in urine extracts 142
Behaviour of human lymphocytic isoenzymes of 5' nucleotidase 142
Markers di malattie neoplastiche in patologia digestiva. Determinazione dell'oncogene NEU nella diagnosi dei tumori colonrettali 142
Uno studio pilota sulla concentrazione plasmatica di aripiprazolo. 141
Purine metabolism in regenerating liver bearing rats 140
Antioxidant status and purine bases in carotid artery plaque 140
Diagnostic accuracy of anti-phospholipase A2 receptor (PLA2R) antibodies in idiopathic membranous nephropathy: an Italian experience 140
Blood concentrations of lead and erythropoietin 139
Purine nucleotide catabolism in rat liver. Labelling of uric acid and allantoin after treatment with oxonic acid and allopurinol 139
Correlazione tra concentrazione plasmatica, efficacia e tollerabilità in un gruppo di pazienti trattati con aripiprazolo. 139
Melting Temperature Analysis as quantitative method for detection of point mutations 138
Assessment of a combination screening assay for celiac disease 137
Dosaggio del Dabigatran in urgenza 137
Prelievi anche nel pomeriggio e stop al digiuno: innovazioni per una Medicina di Laboratorio 4.0. 137
Alcuni aspetti del metabolismo purinico in tumori umani. Correlazioni dei livelli plasmatici delle ossipurine con vari parametri 136
Antioxidant status and purine bases in carotid artery plaque 136
Erythropoietin and transferrin concentrations during pregnancy in relation to hemoglobin levels 135
M2-specific anti-mitochondrial antibodies, positive on Hep-2 cells and negative on triple tissue: Indications for a correct diagnostic strategy [Anticorpi anti-mitocondri con specificità M2, positivi su cellule HEp-2 e negativi su triplo tessuto: indicazioni per una corretta strategia diagnostica] 135
High levels of soluble ctla-4 are present in anti-mitochondrial antibody positive, but not in antibody negative patients with primary biliary cirrhosis. 134
EPR spin trapping of a radical intermediate in the urate oxidase reaction 134
Pattern of vitamin B12 and folic acid during pregnancy 133
Labelling of urinary uric acid and allantoin 133
Overcoming a "probable" diagnosis in antimitochondrial antibody negative primary biliary cirrhosis: study of 100 sera and review of the literature 133
Proteomic analysis of atherosclerotic plaque 132
Stability of serum and plasma ascorbic acid 132
Markers di malattie neoplastiche in patologia digestiva. Le basi metilate urinarie nei soggetti portatori di tumore colon-rettale e la loro determinazione 131
Levels and variability of purine nucleotides in normal human lymphocytes 131
Autoantibody profiling of patients with primary biliary cirrhosis using a multiplexed line-blot assay 131
Nitric Oxide levels in patients with atheromatous carotid plaque 130
Markers di malattie neoplastiche in patologia digestiva.Determinazione dell'oncogene NEU nella diagnosi dei tumori colonrettali 130
Comparative determination of purine compounds in carotid paque by capillary zone electrophoresis and high-performance liquid chromatography 130
Combining immunofluorescence with immunoblot assay improves the specificity of autoantibody testing for myositis 130
Comportamento delle purine plasmatiche e urinarie dopo dieta apurinica in soggetti normali e gottosi. 129
Comportamento degli enzimi della via di recupero delle basi puriniche in linfociti leucemici. 129
Pattern of methylated purine bases in urine of cancer patients. Analysis by mass spectrometry 128
Diagnosi biochimica dei tumori colon-rettali: ruolo dell'adenilosuccinico liasi. 128
Purine nucleotide catabolism in rat liver. 127
Clearance delle ossipurine nei soggetti normali e nei soggetti gottosi sottoposti a dieta apurinica. Effetti dell'allopurinolo. 126
Behavior of oxypurines in normal subjects after an 8 day purine-free diet 126
Assessment of a combination screening assay for celiac disease 125
Purine nucleotide catabolism in rat liver after castration 125
Markers di malattie neoplastiche in patologia digestiva. Gli enzimi del punto di incrocio inosinico nella mucosa colonrettale normale e tumorale 124
Purine nucleotide catabolism in rat liver 124
Enzimi del punto d'incrocio inosinico in linfociti umani. 123
Purine nucleotide catabolism in rat liver. Certain preliminary aspects of uricase reaction 123
Fast-Atom Bombardment mass spectrometry for mapping of endogenous methylated purine bases in urine extracts 123
Markers di malattie neoplastiche in patologia digestiva. Le basi metilate urinarie nei soggetti portatori di tumore colon-rettale e la loro determinazione 121
Purine nucleotide catabolism in rat liver 121
Purine nucleotide catabolism in rat liver after castration 121
Detection of autoantibodies against actin filaments in celiac disease 121
Purine nucleotide catabolism in rat liver labelling of uric acid and allantoin after administration of various labelled precursors. 120
Markers of gluten sensitivity in unipolar and bipolar disorders. 119
Nitrogen metabolism during liver regeneration 119
Positive tissue transglutaminase antibodies with negative endomysial antibodies: Unresolved issues in diagnosing celiac disease 119
Clearance of oxypurines and uric acid in gouty patients [Clearance delle ossipurine e dell'acido urico in soggetti gottosi] 118
The use of VNTRS in the haplotypic characterization of retinoblastoma patients and their familiars 118
Tocilizumab, Adipokines and Severe Complications of COVID-19 118
Osservazioni sul metabolismo aminoacidico in corso di peritonite sperimentale 117
null 117
Liquid Chromatography/Electrospray Tandem Mass Spectrometry of methylated purine bases 117
Immunohistochemical analysis of p185 in normal and trasformed human tissues 116
Plasma and urinary oxypurines in Lesch-Nyhan patient after allopurinol treatment 115
Totale 14.779
Categoria #
all - tutte 100.131
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 100.131


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.395 0 0 0 0 0 0 0 0 347 537 147 364
2020/20214.121 218 425 114 369 247 502 151 676 565 252 387 215
2021/20223.116 157 375 229 346 131 75 117 149 132 351 273 781
2022/20235.006 297 296 713 709 510 1.007 124 385 560 123 182 100
2023/20243.641 142 83 280 148 148 1.089 1.211 108 30 107 44 251
2024/20254.031 155 408 610 361 895 368 163 393 678 0 0 0
Totale 30.867